These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21082324)

  • 21. Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinson's disease.
    Shohet A; Khlebtovsky A; Roizen N; Roditi Y; Djaldetti R
    Eur J Pain; 2017 Mar; 21(3):486-493. PubMed ID: 27723182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative sensory testing and pain tolerance in patients with mild to moderate Alzheimer disease compared to healthy control subjects.
    Jensen-Dahm C; Werner MU; Dahl JB; Jensen TS; Ballegaard M; Hejl AM; Waldemar G
    Pain; 2014 Aug; 155(8):1439-1445. PubMed ID: 24412285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pain-pressure threshold in patients with Parkinson's disease with and without dyskinesia.
    Vela L; Lyons KE; Singer C; Lieberman AN
    Parkinsonism Relat Disord; 2007 Apr; 13(3):189-92. PubMed ID: 16784881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiology of pain and fatigue in Parkinson's disease.
    Berardelli A; Conte A; Fabbrini G; Bologna M; Latorre A; Rocchi L; Suppa A
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S226-8. PubMed ID: 22166442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pain sensitivity and clinical progression in Parkinson's disease.
    Mylius V; Brebbermann J; Dohmann H; Engau I; Oertel WH; Möller JC
    Mov Disord; 2011 Oct; 26(12):2220-5. PubMed ID: 21766333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Facilitated temporal summation of pain at spinal level in Parkinson's disease.
    Perrotta A; Sandrini G; Serrao M; Buscone S; Tassorelli C; Tinazzi M; Zangaglia R; Pacchetti C; Bartolo M; Pierelli F; Martignoni E
    Mov Disord; 2011 Feb; 26(3):442-8. PubMed ID: 21462260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between pain and motor and non-motor symptoms in Parkinson's disease.
    Defazio G; Antonini A; Tinazzi M; Gigante AF; Pietracupa S; Pellicciari R; Bloise M; Bacchin R; Marcante A; Fabbrini G; Berardelli A
    Eur J Neurol; 2017 Jul; 24(7):974-980. PubMed ID: 28516474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinical survey of pain in Parkinson's disease in Eastern China.
    Lin XJ; Yu N; Lin XG; Zhang YF; Chen Y; Zhang K; Wang XS; Liu WG
    Int Psychogeriatr; 2016 Feb; 28(2):283-9. PubMed ID: 26443237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative impact of severity of pain on mood, social life and general activity in Parkinson's disease.
    Rana AQ; Qureshi ARM; Haris A; Danish MA; Furqan MS; Shaikh O; Sarfraz Z; Rana R
    Neurol Res; 2018 Dec; 40(12):1054-1059. PubMed ID: 30221591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nociceptive brain activation in patients with neuropathic pain related to Parkinson's disease.
    Brefel-Courbon C; Ory-Magne F; Thalamas C; Payoux P; Rascol O
    Parkinsonism Relat Disord; 2013 May; 19(5):548-52. PubMed ID: 23462484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of low-frequency deep brain stimulation on sensory thresholds in Parkinson's disease.
    Belasen A; Rizvi K; Gee LE; Yeung P; Prusik J; Ramirez-Zamora A; Hanspal E; Paiva P; Durphy J; Argoff CE; Pilitsis JG
    J Neurosurg; 2017 Feb; 126(2):397-403. PubMed ID: 27104841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.
    Brefel-Courbon C; Payoux P; Thalamas C; Ory F; Quelven I; Chollet F; Montastruc JL; Rascol O
    Mov Disord; 2005 Dec; 20(12):1557-63. PubMed ID: 16078219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thermal and mechanical pain thresholds in patients with fluctuating Parkinson's disease.
    Vela L; Cano-de-la-Cuerda R; Fil A; Muñoz-Hellín E; Ortíz-Gutiérrez R; Macías-Macías Y; Fernández-de-Las-Peñas C
    Parkinsonism Relat Disord; 2012 Sep; 18(8):953-7. PubMed ID: 22658653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
    Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
    J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscular pain in Parkinson's disease and nociceptive processing assessed with CO2 laser-evoked potentials.
    Tinazzi M; Recchia S; Simonetto S; Tamburin S; Defazio G; Fiaschi A; Moretto G; Valeriani M
    Mov Disord; 2010 Jan; 25(2):213-20. PubMed ID: 20063386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The threshold of pain and neurotransmitter's change on pain in Parkinson's disease.
    Urakami K; Takahashi K; Matsushima E; Sano K; Nishikawa S; Takao T
    Jpn J Psychiatry Neurol; 1990 Sep; 44(3):589-93. PubMed ID: 1705999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recovery of Impaired Endogenous Pain Modulation by Dopaminergic Medication in Parkinson's Disease.
    Florin E; Koschmieder KC; Schnitzler A; Becker S
    Mov Disord; 2020 Dec; 35(12):2338-2343. PubMed ID: 32945583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of Dopaminergic Medication on Conditioned Pain Modulation in Parkinson's Disease Patients.
    Grashorn W; Schunke O; Buhmann C; Forkmann K; Diedrich S; Wesemann K; Bingel U
    PLoS One; 2015; 10(8):e0135287. PubMed ID: 26270817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative Sensory Testing (QST) in Drug-Naïve Patients with Parkinson's Disease.
    Fründt O; Grashorn W; Buhmann C; Forkmann K; Mainka T; Bingel U; Schmidt K
    J Parkinsons Dis; 2019; 9(2):369-378. PubMed ID: 30829618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatosensory temporal discrimination threshold in Parkinson's disease parallels disease severity and duration.
    Conte A; Leodori G; Ferrazzano G; De Bartolo MI; Manzo N; Fabbrini G; Berardelli A
    Clin Neurophysiol; 2016 Sep; 127(9):2985-2989. PubMed ID: 27458837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.